Document Detail


Thyrotoxicosis during pregnancy.
MedLine Citation:
PMID:  84547     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The diagnosis of thyrotoxicosis during pregnancy is difficult on clinical grounds only. The determination of free thyroid hormones or free thyroid hormone indices is important and is possibly supplemented by the TRH stimulation test. Thyrotoxicosis during pregnancy should always be treated actively. The authors recommend subtotal thyroidectomy if there are indications for surgical therapy (nodular goitre or large diffuse goitre). Otherwise treatment with thyrostatic agents is used. After operation during pregnancy, substitution with thyroid hormones should be given throughout the pregnancy in order to avoid deterious effects of possible maternal hypothyroidism. Antithyroid treatment should be continued till after delivery. Beta-receptor blockers are used only as adjuncts but are not recommended as the sole therapy.
Authors:
F Pekonen; B A Lamberg
Related Documents :
19300337 - Thyroid dysfunction in pregnancy: the basic science and clinical evidence surrounding t...
16305567 - Changes in gustatory function during the course of pregnancy and postpartum.
9253317 - Thyroiditis after pregnancy loss.
17077257 - Thyroid disease in pregnancy.
20528567 - Pregnancy outcome in immigrant women with gestational diabetes mellitus.
6832047 - Identification and partial characterization of a lactogen from the midpregnant mouse co...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annales chirurgiae et gynaecologiae     Volume:  67     ISSN:  0355-9521     ISO Abbreviation:  Ann Chir Gynaecol     Publication Date:  1978  
Date Detail:
Created Date:  1979-04-28     Completed Date:  1979-04-28     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  7609767     Medline TA:  Ann Chir Gynaecol     Country:  FINLAND    
Other Details:
Languages:  eng     Pagination:  165-73     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Antibodies
Antithyroid Agents / therapeutic use
Female
Humans
Hyperthyroidism* / diagnosis,  drug therapy,  surgery
Immunoglobulins
Pregnancy
Pregnancy Complications* / diagnosis,  drug therapy,  surgery
Thyroid Gland / immunology
Thyrotropin / blood
Thyrotropin-Releasing Hormone / diagnostic use
Thyroxine / blood
Triiodothyronine / blood
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Antibodies; 0/Antithyroid Agents; 0/Immunoglobulins; 24305-27-9/Thyrotropin-Releasing Hormone; 6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors affecting the fibrinolytic response to surgery.
Next Document:  Effect of S-adenosyl-L-methionine on the cerebral and peripheral metabolism of L-dopa